Page last updated: 2024-08-17

medroxyprogesterone acetate and Neoplasm Metastasis

medroxyprogesterone acetate has been researched along with Neoplasm Metastasis in 87 studies

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	52 (59.77)	18.7374
1990's	19 (21.84)	18.2507
2000's	9 (10.34)	29.6817
2010's	6 (6.90)	24.3611
2020's	1 (1.15)	2.80

Authors

Authors	Studies
Bispo, D; Fabris, V; Gil, AM; Helguero, LA; Lamb, CA; Lanari, C	1
Bing, S; Lijuan, D; Santai, S; Shaohua, Z; Shikai, W; Tao, W; Xiangying, M; Xin, Z; Yan, M; Yue, W; Zefei, J	1
Iwase, H	1
Iwase, H; Yamamoto, Y	1
Makris, A; Miles, D; Sutherland, S	1
Cao, Q; Feng, W; Feng, Y; Hua, K; Lu, X; Zhou, X	1
Mueck, AO; Seeger, H; Wallwiener, D	1
Collins, J; Marino, N; Marshall, JC; Steeg, P	1
Mizuno, M; Nakanishi, T; Nawa, A; Yatabe, Y	1
MADDEN, EP	1
Halverson, D; Ouatas, T; Steeg, PS	1
Armstrong, DK; Brunetto, VL; Lee, RB; Lentz, SS; Sorosky, J; Whitney, CW; Zaino, RJ	1
Efeyan, A; Fabris, V; Lanari, C; Merani, S; Molinolo, AA	1
Gorbunova, VA; Howell, A; Lichinitser, MR; Pienkowski, T; Robertson, JF; Watanabe, T	1
Halverson, DO; Horak, CE; Lee, JH; Palmieri, D; Steeg, PS	1
Hasumi, H; Izumi, K; Kanno, H; Mikata, K; Nagashima, Y; Osada, Y; Otai, J; Tsuchiya, F; Umemoto, S	1
Iida, K; Ishibashi, M; Katagiri, A; Miyazaki, K; Nakayama, K; Nakayama, N; Shamima, Y	1
Blossey, HC; Koebberling, J; Nagel, GA; Wander, HE	1
Kaufman, R; Kinne, D; Kraybill, WG	1
De Lena, M; Di Fronzo, G; Villa, S	1
Blossey, HC; Kleeberg, U; Köbberling, J; Nagel, GA; Wander, HE	1
Blossey, HC; Nagel, GA; Wander, HE	1
Murphy, GP	1
Bartsch, HH; Blossey, HC; Nagel, GA	1
Bastert, G; Michel, RT	1
Barduagni, A; Barduagni, M; Di Lauro, L; Lopez, M; Papaldo, P; Perno, CF	1
Alberto, P; Cavalli, F; Goldhirsch, A; Jungi, F; Martz, G	1
Fotherby, K; Johnson, JR; Kelly, KA; Priestman, SG; Priestman, TJ	1
Coates, A; Dalgleish, A; Fox, R; Hedley, D; Raghavan, D; Tattersall, MH	1
Garbrecht, M; Kleeberg, UR; Müllerleile, U; Pompecki, R; Treidler, J	1
Baroni, M; Farris, A; Grieco, A; Martoni, A; Pannuti, F; Piana, E; Saccani, F; Tomasi, L	1
Cappelletti, V; Di Fronzo, G; Dormia, E; Giannoni, R; Giongo, A; Lasio, E; Maffeis, V; Piva, L; Pizzocaro, G; Ronchi, E; Salvioni, R; Zanollo, A	1
Asselain, B; Bretaudeau, B; Giralt, E; Jouve, M; Magdelenat, H; Merle, S; Palangie, T; Pouillart, P; Zajdela, A	1
Di Marco, AR; Fruet, F; Martoni, A; Pannuti, F; Strocchi, E	1
Isojima, S; Kawakita, M; Koyama, K; Nakata, Y; Ogasawara, T; Takemura, T; Tsuji, Y	1
Cook, PA; Donaldson, N; Fayers, PM; Machin, D; Oliver, RT; Ritchie, A; Whitehead, J; Yuen, P	1
Gundersen, S; Hannisdal, E; Lundgren, S; Wist, E	1
Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Ferri, L; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Omodei Zorini, C	1
Hirata, S; Ikeda, K; Kubo, Y; Maeda, T; Nakajima, S; Sasajima, T; Yamazaki, K	1
Brockerhoff, P; Hofmann, M; Holzer, A; Rathgen, GH	1
Falkson, CB; Falkson, CI; Falkson, G; Falkson, HC	2
Dohi, K; Gotoh, T; Kataoka, T; Nishiki, M; Okamoto, T; Sadamoto, S	1
Beck, T; Crombach, G; Kreienberg, R; Möbus, V; Paula, J	1
Bianco, AR; Carlomagno, C; De Placido, S; Lauria, R; Morabito, A; Perrone, F	1
Baba, K; Fukuda, M; Higuchi, A; Ikeda, K; Matsuda, M; Matsuoka, Y; Nagao, K; Nishimura, R; Yamashita, H	1
Amato, R	1
Gundersen, S; Hannisdal, E; Høst, H; Klepp, O; Kvinnsland, S; Lund, E	1
Brockerhoff, P; Grill, HJ; Holzer, A; Kreienberg, R; Pollow, K; Rathgen, GH; Schicketanz, KH; Schwarz, V	1
Namer, M	1
Falk, W; Halama, J; Halama, JM	1
Biakhov, MIu; Meshcheriakova, NG; Vasiuta, NIu; Voznyĭ, EK	1
Buzdar, AU; Fritsche, HA; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, SW	1
Dryzhak, VI	1
Geyer, H; Neulen, J; Pfleiderer, A; Runge, HM; Teufel, G	1
Cozzoli, A; Di Fronzo, G; Dormia, E; Fontanella, U; Giongo, A; Minervini, S; Piva, L; Pizzocaro, G; Ronchi, E; Zanollo, A	1
Samonigg, H	1
Schweitzer, MJ; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH	1
Bonichon, F; Chauvergne, J; Durand, M; Mauriac, L	1
Ashley, S; Coombes, RC; Goss, PE; Powles, TJ	1
Bensimon, H; Bunn, PA; Cohen, MH; Dunnick, NR; Eddy, JL; Ihde, DC; Javadpour, N; Makuch, RW; Minna, JD; Seifter, EJ	1
Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE	1
Andersen, AP; Brincker, H; Dombernowsky, P; Frederiksen, PL; Hansen, PV; Hesselius, I; Jakobsen, A; Kjaer, M; Møller, KA	1
Frenay, M; Khater, R; Milano, G; Namer, M; Renée, N; Thyss, A	1
Atkinson, EN; Freedman, RS; Jones, LA; Kline, RC	1
Manni, A	1
Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M	1
Emrich, D; Luig, H; Nagel, GA; Wander, HE	1
Hasford, J; Messerer, D; Neiss, A; Porzsolt, F	1
Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE	1
Langecker, P; Possinger, K; Schmid, L; Wagner, H; Willich, S; Wilmanns, W	1
Blossey, HC; Essers, U; Kleeberg, UR; Nagel, GA; Wander, HE	1
Flamm, J; Spona, J	1
Balogh, F; Romics, I	1
Becher, R; Miller, AA; Schmidt, CG	1
Alford, WM; Ehrlich, CE; Stehman, FB; Sutton, GP; Young, PC	1
Cairns, V; Davila, E; East, D; Hilsenbeck, S; Vogel, CL	1
Blomqvist, C; Elomaa, I; Mäntylä, M; Rissanen, P	1
Camaggi, CM; Pannuti, F; Strocchi, E	1
Bollack, C; Rougeron, G	1
Glick, JH; Haller, DG	1
Blijham, GH; Mellink, WA; Meulenberg, PM; Van Deijk, WA	1
Crawford, ED; Gottesman, JE; Grossman, HB; McCracken, JD; Scardino, P	1
Cremer, P; Kruse, B; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H	1
Mortel, R; Satyaswaroop, PG; Whitney, CW	1
Blumenschein, GR; Buzdar, AU; Fraschini, G; Frye, D; Halvorson, HC; Hortobagyi, GN; Hug, V; Pinnamaneni, K; Yap, HY	1

Reviews

8 review(s) available for medroxyprogesterone acetate and Neoplasm Metastasis

Article	Year
Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor. International journal of clinical oncology, 2015, Volume: 20, Issue:2 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction	2015
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:2 Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Ovariectomy; Postmenopause; Premenopause; Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen	2015
Use of maintenance endocrine therapy after chemotherapy in metastatic breast cancer. European journal of cancer (Oxford, England : 1990), 2016, Volume: 69 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Trastuzumab	2016
The Nm23-H1 metastasis suppressor as a translational target. European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:7 Topics: Animals; Antineoplastic Agents; Genetic Therapy; Humans; Lysophospholipids; Medroxyprogesterone Acetate; Mice; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Translational Research, Biomedical	2010
Translational approaches using metastasis suppressor genes. Journal of bioenergetics and biomembranes, 2006, Volume: 38, Issue:3-4 Topics: Animals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Histidine Kinase; Humans; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Protein Kinases	2006
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Neoplasm Metastasis; Pleural Effusion, Malignant	1995
[Estrogen antagonists and inhibitors in hormone therapy of breast cancer]. Voprosy onkologii, 1989, Volume: 35, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Progestins; Tamoxifen	1989
Tamoxifen therapy of metastatic breast cancer. The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:3 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen	1987

Trials

27 trial(s) available for medroxyprogesterone acetate and Neoplasm Metastasis

Article	Year
Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecologic oncology, 2004, Volume: 92, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen	2004
5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer. Tumori, 1983, Dec-31, Volume: 69, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1983
Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5 Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation; Time Factors	1984
Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
[Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate]. Bulletin du cancer, 1984, Volume: 71, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Receptors, Cell Surface; Tamoxifen; Time Factors	1984
Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results. European journal of cancer, 1980, Volume: Suppl 1 Topics: Administration, Oral; Aged; Body Weight; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen	1980
On the development of the Medical Research Council trial of alpha-interferon in metastatic renal carcinoma. Urological Working Party Renal Carcinoma Subgroup. Statistics in medicine, 1994, Nov-15, Volume: 13, Issue:21 Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Humans; Interferon-alpha; Kidney Neoplasms; London; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Nephrectomy; Probability; Prognosis; Sampling Studies; Time Factors; United Kingdom	1994
Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1994
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients]. La Clinica terapeutica, 1994, Volume: 145, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Time Factors	1994
[Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate	1993
A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancer. American journal of clinical oncology, 1993, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Neoplasm Metastasis; Survival Analysis	1993
Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen; Soft Tissue Neoplasms; Treatment Outcome	1997
Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators. Lancet (London, England), 1999, Jan-02, Volume: 353, Issue:9146 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Female; Humans; Interferon-alpha; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Nephrectomy; Registries; Survival Analysis; United Kingdom	1999
Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer. Oncology, 1992, Volume: 49, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Neoplasm Metastasis; Pilot Projects	1992
Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer. Norwegian Breast Cancer Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycins; Neoplasm Metastasis; Neoplasm Proteins; Receptors, Estrogen; Vincristine	1992
[Hormone receptors and endocrine therapy of renal carcinoma]. La Ricerca in clinica e in laboratorio, 1985, Volume: 15 Suppl 2 Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Random Allocation; Receptors, Estrogen	1985
Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer. Cancer, 1986, Jul-01, Volume: 58, Issue:1 Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Random Allocation; Tamoxifen	1986
[Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications]. Bulletin du cancer, 1986, Volume: 73, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1986
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Drug Therapy, Combination; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Orchiectomy; Pilot Projects; Prostatic Neoplasms	1986
Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:9 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prednisone; Random Allocation	1986
Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate. Cancer treatment reports, 1987, Volume: 71, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Uterine Neoplasms	1987
Tamoxifen therapy of metastatic breast cancer. The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:3 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen	1987
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer. Onkologie, 1986, Volume: 9, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine	1986
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c]. Onkologie, 1987, Volume: 10, Issue:1 Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Interferon Type I; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Random Allocation; Recombinant Proteins	1987
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study]. Onkologie, 1987, Volume: 10, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation	1987
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]. Onkologie, 1987, Volume: 10, Issue:5 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cortisone; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Random Allocation	1987
Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial. Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation	1988

Other Studies

53 other study(ies) available for medroxyprogesterone acetate and Neoplasm Metastasis

Article	Year
Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures. Biomolecules, 2020, 08-27, Volume: 10, Issue:9 Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Female; Glucose; Glycolysis; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Metabolome; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms, Hormone-Dependent	2020
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer. Swiss medical weekly, 2013, Volume: 143 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome	2013
Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. International journal of oncology, 2008, Volume: 33, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Movement; Cystadenoma, Serous; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Progestins; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Time Factors	2008
Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:10 Topics: Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Neoplasm Metastasis; Progestins; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2008
Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma. International journal of clinical oncology, 2012, Volume: 17, Issue:4 Topics: Adult; Antineoplastic Agents, Hormonal; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Sarcoma, Endometrial Stromal; Survival Analysis; Uterine Neoplasms	2012
A PROGESTATIONAL AGENT (MEDROXYPROGESTERONE ACETATE) IN TREATMENT OF PRIMARY ADENOCARCINOMA OF THE CERVIX. REPORT OF A CASE. Obstetrics and gynecology, 1964, Volume: 23 Topics: Adenocarcinoma; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Pathology; Progestins; Radiography, Thoracic; Uterine Cervical Neoplasms	1964
Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1 Topics: Agar; Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mutagenesis; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Promoter Regions, Genetic; Protein Biosynthesis; RNA Processing, Post-Transcriptional; Time Factors; Transcription, Genetic; Transfection	2003
Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor. Breast cancer research and treatment, 2004, Volume: 83, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Estradiol; Female; Gene Expression Regulation, Neoplastic; Genetic Markers; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lung Neoplasms; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	2004
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant. Breast cancer research and treatment, 2005, Volume: 92, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Retrospective Studies; Salvage Therapy; Tamoxifen; Treatment Outcome	2005
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration]. Hinyokika kiyo. Acta urologica Japonica, 2007, Volume: 53, Issue:9 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Etoposide; Humans; Interferon-alpha; Interferon-gamma; Male; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nephrectomy; Thiotepa	2007
[Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:5 Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Sarcoma, Endometrial Stromal	2008
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer, 1984, Sep-15, Volume: 54, Issue:6 Suppl Topics: Adrenocorticotropic Hormone; Antineoplastic Agents; Breast Neoplasms; Female; Gonadotropins; Humans; Hydrocortisone; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Progesterone; Thyrotropin-Releasing Hormone	1984
Treatment of advanced male breast cancer. Cancer, 1981, May-01, Volume: 47, Issue:9 Topics: Breast Neoplasms; Castration; Diethylstilbestrol; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Palliative Care; Prognosis; Receptors, Estrogen	1981
Therapeutic activity of medroxyprogesterone acetate in metastatic breast cancer: a correlation between estrogen receptors and various dosages. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1984, Volume: 91 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Receptors, Estrogen	1984
[High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration]. Onkologie, 1982, Volume: 5 Suppl Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Female; Humans; Hydrocortisone; Injections, Intramuscular; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Tablets	1982
[Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force]. Onkologie, 1982, Volume: 5 Suppl Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1982
Murine renal cell carcinoma: a suitable human model. Progress in clinical and biological research, 1982, Volume: 100 Topics: Adenocarcinoma; Animals; Diethylstilbestrol; Disease Models, Animal; Female; Humans; Kidney Neoplasms; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Testosterone	1982
[Mitomycin C and high-dosage medroxyprogesterone acetate in the therapy of metastasizing breast cancer. Results of a phase II study of the Workshop for Internal Oncology of the German Cancer Association]. Onkologie, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Germany, West; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycins; Neoplasm Metastasis	1982
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma]. Die Medizinische Welt, 1983, Mar-25, Volume: 34, Issue:12 Topics: Administration, Oral; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Tablets	1983
An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer. British journal of cancer, 1984, Volume: 50, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local	1984
Advanced breast cancer: response to high dose oral medroxyprogesterone acetate. Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis	1984
[Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma]. Onkologie, 1984, Volume: 7, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis	1984
Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective study. Tumori, 1983, Jun-30, Volume: 69, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Nephrectomy; Prospective Studies; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Testosterone	1983
Progesterone treatment decreases sulfate carbohydrate antigen on endometrial carcinoma cells and inhibits the cell binding to laminin. Gynecologic oncology, 1995, Volume: 57, Issue:3 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Carbohydrate Sequence; Endometrial Neoplasms; Epitopes; Female; Humans; Immunohistochemistry; Laminin; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Sulfates; Tumor Cells, Cultured	1995
[Plasma concentrations of non-esterified fatty acids and lipids in high-dose medroxyprogesterone therapy of metastatic breast cancer]. Zentralblatt fur Gynakologie, 1993, Volume: 115, Issue:11 Topics: Blood Glucose; Breast Neoplasms; Cholesterol; Fatty Acids, Nonesterified; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Phospholipids; Prospective Studies; Reference Values; Triglycerides	1993
[A case of breast cancer with multiple organ metastases in which single low dose administration of 5'-DFUR proved effective]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Quality of Life; Tamoxifen	1993
[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer]. Geburtshilfe und Frauenheilkunde, 1993, Volume: 53, Issue:1 Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent	1993
Modest effect of interferon alfa on metastatic renal-cell carcinoma. Lancet (London, England), 1999, Jan-02, Volume: 353, Issue:9146 Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Interferon-alpha; Kidney Neoplasms; Medroxyprogesterone Acetate; Neoplasm Metastasis; Randomized Controlled Trials as Topic; Survival Analysis	1999
[Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer]. Gynakologische Rundschau, 1991, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prospective Studies	1991
[Reflexions on hormone therapy of cancer of the breast]. Bulletin du cancer, 1991, Volume: 78, Issue:11 Suppl Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Ovariectomy; Tamoxifen	1991
[Long-term results in the treatment of 100 metastatic hypernephroid carcinomas]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1990, Volume: 166, Issue:4 Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Kidney Neoplasms; Lymph Node Excision; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Postoperative Care; Radiotherapy; Time Factors	1990
[Hormonal control of disseminated breast cancer]. Sovetskaia meditsina, 1990, Issue:6 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1990
Sequential cyclic combined hormonal therapy for metastatic breast cancer. Cancer, 1989, Sep-01, Volume: 64, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone	1989
In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Adenocarcinoma; Aged; Cell Division; Cells, Cultured; Estradiol; Estrogen Antagonists; Ethanol; Female; Gestonorone Caproate; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplastic Stem Cells; Ovarian Neoplasms; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1986
[Value of hormone therapy in metastasizing breast cancer]. Wiener medizinische Wochenschrift (1946), 1985, Dec-31, Volume: 135, Issue:23-24 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Ovariectomy; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1985
High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer. Cancer treatment reports, 1986, Volume: 70, Issue:6 Topics: Adult; Aged; Breast Neoplasms; Edema; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Respiration Disorders	1986
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO). Cancer, 1986, Nov-01, Volume: 58, Issue:9 Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain	1986
Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer. Breast cancer research and treatment, 1986, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen	1986
Intensive short-term chemotherapy in patients with advanced breast cancer. Klinische Wochenschrift, 1987, Apr-01, Volume: 65, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Remission Induction; Vincristine	1987
[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy]. Fortschritte der Medizin, 1987, Jul-30, Volume: 105, Issue:22 Topics: Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Prognosis	1987
[High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer]. Wiener klinische Wochenschrift, 1987, Oct-09, Volume: 99, Issue:19 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone	1987
[Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1987
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer. Journal of cancer research and clinical oncology, 1988, Volume: 114, Issue:2 Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay	1988
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. American journal of obstetrics and gynecology, 1988, Volume: 158, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Injections, Intramuscular; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1988
Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature. Cancer, 1988, Jun-01, Volume: 61, Issue:11 Topics: Administration, Oral; Breast Neoplasms; Dose-Response Relationship, Drug; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Prospective Studies; Time Factors	1988
The role of pharmacokinetics in the clinical treatment of metastases. Advances in experimental medicine and biology, 1988, Volume: 233 Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms; Tamoxifen	1988
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study. American journal of clinical oncology, 1988, Volume: 11 Suppl 2 Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms	1988
Progestational agents in advanced breast cancer: an overview. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen	1986
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol. Cancer treatment reports, 1985, Volume: 69, Issue:1 Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Pilot Projects	1985
Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study. Urology, 1985, Volume: 25, Issue:3 Topics: Carcinoma, Renal Cell; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Nephrectomy; Renal Artery; Time Factors	1985
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors]. Onkologie, 1985, Volume: 8, Issue:2 Topics: Aminoglutethimide; Breast Neoplasms; Cholesterol; Cortisone; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Triglycerides	1985
Plasminogen activator activity in human endometrial carcinoma. Gynecologic oncology, 1985, Volume: 22, Issue:1 Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Plasminogen Activators; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1985
Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast cancer research and treatment, 1985, Volume: 5, Issue:3 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone	1985